The expanded indication was supported by data from a phase 1/2 pharmacokinetics (PK) study (ClinicalTrials.gov Identifier: NCT05076838) that evaluated diazepam nasal spray in pediatric epilepsy ...

Can a nasal spray slow down Alzheimer’s? ... Howard Weiner, a professor at Harvard and neurologist at Mass General Brigham, says the treatment was producing good results with MS patients.

Dosing began at Weill Cornell Medical Center in a Phase 2a trial testing foralumab nasal spray in people with nonactive SPMS.

In late 2024, Karen brought Joe to Dr. Seth Gale, a neurologist at Mass General Brigham and Harvard Medical School who promised to look for a research study Walsh could enter.

The nasal spray contains an experimental monoclonal antibody meant to reduce the Alzheimer’s-related inflammation in Walsh’s brain. ... In late 2024, Karen brought Joe to Dr. Seth Gale, a neurologist ...

In late 2024, Karen brought Joe to Dr. Seth Gale, a neurologist at Mass General Brigham and Harvard Medical School who promised to look for a research study Walsh could enter.

Can a nasal spray slow down Alzheimer's? ... Howard Weiner, a professor at Harvard and neurologist at Mass General Brigham, says the treatment was producing good results with MS patients.

Can a nasal spray slow down Alzheimer's? ... Howard Weiner, a professor at Harvard and neurologist at Mass General Brigham, says the treatment was producing good results with MS patients.

The nasal spray contains an experimental monoclonal antibody meant to reduce the Alzheimer's-related inflammation in Walsh's brain. He is the first person living with Alzheimer's to get the ...

Researchers think an experimental anti-inflammatory drug for people with multiple sclerosis might help Alzheimer's patients. And they've already tried it on a man named Joe.